P ERIODS OF VOLUNTARY ABStinence from food and drink (ie, intermittent fasting) has been practiced since earliest antiquity by peoples around the globe. Books on ethnology and religion describe a remarkable variety of fasting forms and practices. 1 Renewed interest in fasting regimens is evidenced by a plethora of popular press publications and diet recommendations. For example, in 2013, Mosley and Spencer 2 published a best-selling book titled The Fast Diet, which touts the benefits of restricting energy intake severely for 2 days a week while eating normally the rest of the week. Dozens of books promote various fasting dietary patterns and the web offers hundreds of fasting-related sites. However, scientific evidence for the health benefits of intermittent fasting in human beings is often extrapolated from animal studies, based on observational data on religious fasting (particularly R amadan), or derived fro m experimental studies with modest sample sizes.
Our overall objective is to provide an overview of intermittent fasting regimens ( Figure 1 ) and summarize the evidence on the health benefits of intermittent fasting with a focus on human intervention studies. Because much of the data on intermittent fasting are from research in animal models, we briefly summarize key rodent studies and reviews. Health outcomes of interest are changes in weight and metabolic parameters associated with type 2 diabetes, cardiovascular disease, and cancer. We also present an overview of the major mechanisms hypothesized to link fasting regimens with human health; that is, circadian biology; the gastrointestinal microbiota; and modifiable lifestyle behaviors such as diet, activity, and sleep. Finally, we present conclusions regarding the evidence base for intermittent fasting as an intervention for improving human health and propose a research agenda.
We provide a uniquely broad synthesis of the scientific evidence linking intermittent fasting with human health and a framework for future research on this topic.
METHODS
As noted above, we present a brief background of the considerable literature on intermittent fasting in animal models to provide context to the translational research that has been completed in human beings. For human studies, we focus on findings from interventions that examined alternateday fasting, modified fasting regimens, and time-restricted feeding (Figure 1) . A Medline search in PubMed was performed using the terms intermittent fasting, fasting, time-restricted feeding, and food timing. In addition, we culled relevant articles from the reference list of research articles as well as reviews of fasting regimens. 3, 4 Inclusion criteria for human studies were randomized controlled trials and nonrandomized trials; adult male or female participants; and end points of changes in body weight or biomarkers of risk of diabetes, cardiovascular disease, or cancer. This is not a formal review or a meta-analysis. These studies cannot be combined because they are markedly dissimilar with regard to the intervention, the comparison group (or lack thereof), sample composition, study design, and intervention duration. Intermittent fasting performed as a religious practice (eg, Ramadan) is reviewed separately and with less detail because these eating patterns are not motivated by health reasons and have generally been studied using observational study designs.
INTERMITTENT FASTING: HUMAN INTERVENTION TRIALS
This summary emphasizes findings from intervention trials (see the Table) that provide evidence for evaluating the influence of intermittent fasting on human health.
Alternate Day Fasting
Alternate-day fasting involves fasting days in which no energy-containing foods or beverages are consumed alternating with days where foods and beverages are consumed ad libitum. In 2007, Varady and Hellerstein 3 reviewed alternate-day fasting studies in animals and concluded that this fasting regimen was as effective as simple calorie restriction in decreasing fasting insulin and glucose concentrations. Alternate-day fasting in animals also reduced total plasma cholesterol and triglyceride (TG) concentrations, and had beneficial effects on cancer risk factors such as cell proliferation.
To our knowledge, three intervention studies have explored the metabolic effects of alternate-day fasting (see the  Table) . [5] [6] [7] Sample sizes were modest and ranged from 8 to 30 normalweight adults. No information was provided about the physical activity levels of these participants. Two of three studies reported significant weight loss, although we question the clinical relevance of weight loss in a 1-day study. 7 In the 22-day study of alternate-day fasting, participants experienced a mean of 2.5% weight loss (P<0.001). 6 All studies found a significant decrease in at least one glucoregulatory marker. One study examined lipid levels with mixed results: improvements in high-density lipoprotein (HDL) cholesterol and TG, but increased low-density lipoprotein (LDL) cholesterol. One of two studies found significant improvements in inflammatory markers.
Although limited, these data suggest that alternate-day fasting regimens can result in modest weight loss. These data also show some positive effects on metabolic parameters, although these studies enrolled normal-weight adults who were unlikely to show substantial improvements in metabolic risk factors. However, Heilbronn and colleagues 6 noted that self-reported hunger on fasting days was considerable and did not decrease over time, suggesting that alternate-day fasting may not be a feasible public health intervention.
Modified Fasting Regimens
Modified fasting regimens generally allow for the consumption of 20% to 25% of energy needs on regularly scheduled fasting days. In these studies, the term fasting describes periods of severely limited energy intake rather than no energy intake. This regimen is the basis for the popular 5:2 diet, which involves energy restriction for 2 nonconsecutive days a week and usual eating the other 5 days. 2 Varady and colleagues [8] [9] [10] have investigated the effects of modified alternate-day fasting in mice. In a trial comparing 85% energy restriction on alternate fasting days to ad libitum chow, the energy-restricted condition resulted in decreased visceral fat, leptin, and resistin and increases in adiponectin. 11 Similar studies conducted by this research group also found that these fasting regimens in mice appear to reduce adipocyte size, cell proliferation, and levels of insulin-like growth factor-1.
As shown in the Table, we identified eight trials of modified fasting in human beings. [12] [13] [14] [15] [16] [17] [18] [19] Study sample sizes ranged from 10 to 107 adults, all of whom were overweight or obese. The duration of these fasting interventions ranged from 8 weeks to 6 months. Of the eight studies, only one instituted weekly exercise goals. 12 Overall, six of eight studies (75%) reported statistically significant weight loss, which ranged from 3.2% in comparison to a control group 16 over a 12-week period to 8.0% in a one-arm trial over an 8week period. 13 Two of five studies found significant decreases in fasting insulin, but none found reductions in fasting glucose. Three of the eight studies found significant improvements in lipid levels. Two of five studies found significant improvements in inflammatory markers, including C-reactive protein, tumor necrosis factor-alpha (TNF-a), adiponectin, leptin, and brainderived neutrotophic factor. Half of these studies assessed some aspect of mood or other behavior-related side effects in response to the fasting regimen. 13, 15, 18, 19 In general, these studies reported that a small number (generally <15%) of participants reported negative side effects, such as feeling cold, irritable, low energy, or hungry. However, there were mean improvements in mood, including reductions in tension, anger, and fatigue and increases in selfconfidence and positive mood.
Three of the eight trials summarized above compared modified fasting
Complete alternate-day fasting These regimens involve alternating fasting days (no energy-containing foods or beverages consumed) with eating days (foods and beverages consumed ad libitum).
Modified fasting regimens
Modified regimens allow for the consumption of 20% to 25% of energy needs on scheduled fasting days. This regimen is the basis for the popular 5:2 diet, which involves severe energy restriction for 2 nonconsecutive days a week and ad libitum eating the other 5 days.
Time-restricted feeding
These protocols allow individuals to consume ad libitum energy intake within specific windows, which induces fasting periods on a routine basis. Studies of <3 meals per day are indirect examinations of prolonged daily or nightly fasting periods.
Religious fasting
A wide variety of fasting regimens are undertaken for religious or spiritual purposes.
Ramadan fasting
A fast from dawn to sunset during the holy months of Ramadan. The most common dietary practice is to consume 1 large meal after sunset and 1 lighter meal before dawn. Therefore, the feast and fast periods of Ramadan are approximately 12 h in length.
Other religious fasts Latter-day Saints followers routinely abstain from food and drink for extended periods of time. Some Seventh-day Adventists consume their last of 2 daily meals in the afternoon, resulting in an extended nighttime fasting interval that may be biologically important. regimens to simple energy restriction. 12, 15, 18 As shown in the Table, the weight-loss regimens were either 1,200 to 1,500 kcal 12 or 25% energy restriction per day. 15, 18 One of these studies instituted weekly exercise goals. 12 In only one case did the fasting regimen result in significantly more weight loss than a standard weight loss diet (4.1%). 12 In two of these studies, there were significantly reduced insulin concentrations compared with energy restriction, but no other differences in biomarker concentrations. The 12-week, controlled weight-loss trial found that a modified fasting regimen combined with an exercise protocol produced significantly superior weight loss results (6.5%) compared with fasting alone (3.2%) or exercise alone (1.1%). 16 A number of reviews have compared the results of fasting regimens with continuous or daily energy restriction. 20, 21 The most recent of these reviews (conducted in 2014) found that intermittent fasting regimens demonstrated 3% to 8% reductions in body weight after 3 to 24 weeks in comparison to energy restriction, which demonstrated 4% to 14% reductions in weight after 6 to 24 weeks. 21 The authors also reported that these two weight loss strategies yielded comparable reductions in visceral fat mass, fasting insulin, and insulin resistance and no meaningful reductions in fasting glucose concentrations.
Results from these intervention trials of modified fasting regimens suggest that these eating patterns result in weight loss, with modest and mixed effects on glucoregulatory markers, lipid levels, and inflammatory markers. However, there is little evidence to suggest that modified alternateday fasting produces superior weight loss or metabolic changes in comparison to standard energy restriction regimens.
Time-Restricted Feeding
Rothschild and colleagues 4 recently reviewed the animal literature on time-restricted feeding. Twelve studies were identified with daily fasting intervals ranging from 12 to 20 hours, in numerous mouse models, with variability in coordination with light/ dark phases and composition of chow. Despite the heterogeneity of these studies, the authors concluded that in mice, time-restricted feeding was associated with reductions in body weight, total cholesterol, TG, glucose, insulin, interleukin 6, and TNF-a as well as improvements in insulin sensitivity. It is notable that these health outcomes occurred despite variable effects of intermittent fasting on weight loss.
Research in animals highlights the potential importance of synchronizing intermittent fasting regimens with daily circadian rhythms. Animals given unlimited access to a high-fat diet eat frequently throughout the night and the day, disrupting their normal nocturnal feeding cycle. These mice fed an ad libitum high-fat diet develop obesity, diabetes, and metabolic syndrome. However, it was unclear whether these diseases result from the high-fat diets, disruption of circadian rhythms, or both. Compared with ad libitum feeding, mice whose feeding was restricted to normal nocturnal eating times consumed equivalent energy but were protected from obesity, hyperinsulinemia, hepatic steatosis, and inflammation. 22 We were only able to identify two trials in human beings that investigated the effects of time-restricted feeding interventions that extend the duration of nighttime fasting. Neither trial prescribed or measured physical activity. Both of these crossover studies found significant reductions in weight. In the study among 29 normal-weight men (2 weeks per study condition), a prescribed nighttime fasting interval of 11 hours resulted in a significant weight change difference between the intervention (e0.4 kg) and control (þ0.6 kg) conditions, which translates into 1.3% weight loss. 23 No biomarkers were assessed. Another crossover study compared the effect of consuming one afternoon meal per day for 8 weeks and reported 4.1% weight loss in comparison to an isocaloric diet consumed as three meals per day. 24, 25 One meal per day was also associated with reductions in fasting glucose and improvements in LDL and HDL cholesterol levels. Whereas self-reported hunger was higher in the morning for those consuming one meal per day, this fasting regimen was considered acceptable because there were no mean changes in tension, depression, anger, vigor, fatigue, or confusion.
Although clearly limited, results from these studies of time-restricted feeding are consistent with research in animals indicating that incorporation of regular fasting intervals and eating in accordance with normal daily circadian rhythms (ie, daytime hours in human beings) may be important for maintaining optimal metabolic function.
RELIGIOUS FASTING: OBSERVATIONAL RESEARCH
Many religions incorporate fasting for both spiritual and physical benefits. However, published research on these fasting regimens is almost entirely observational. Therefore, we provide only an overview of these fasting regimens.
Ramadan Fasting
One of the five pillars of Islam is that healthy adult Muslims must fast from dawn to sunset during the holy month of Ramadan. In addition, fluid intake, cigarette smoking, and medications are forbidden. Depending on the season and the geographic location of the country, day fasting can vary from 11 to 22 hours. Islamic fasting during Ramadan does not require energy restriction; however, as intake of food and fluid becomes less frequent, changes in body weight may occur.
In 2012 a meta-analysis of 35 studies examined weight change during Ramadan. 26 Across these studies, participant age ranged from 18 to 58 years; just more than half (52%) were conducted in men and women, 34% were in men only, and 11% were in women only. 26 The authors of this review 26 found statistically significant weight loss in 21 (62%) of these studies. When pooled, the studies in this metaanalysis showed a 1.24-kg weight reduction (95% CI e1.60 to e0.88 kg) over the month of Ramadan fasting. Across 16 follow-up studies, mean weight regain was 0.72 kg (95% CI 0.32 to 1.13 kg) in the 2 weeks following Ramadan.
A 2013 meta-analysis of 30 cohort studies including healthy young men and women examined whether Ramadan fasting altered biomarkers in addition to weight. 27 The primary finding of this meta-analysis was that after Ramadan fasting, LDL cholesterol cardiovascular disease, and cancer and fasting blood glucose levels were decreased in both sex groups and also in the entire group compared with levels before Ramadan. 27 In women only, HDL cholesterol levels were significantly increased. In men, there was a significant decrease in weight, total cholesterol level, and TG level. Some studies have reported that Ramadan fasts are associated with significantly lower concentrations of inflammatory markers such as C-reactive protein, interleukin-6, and TNF-a. 28, 29 Ramadan is the most common form of time-restricted feeding and results in transitory weight loss, with mixed evidence for improvements in metabolic markers. However, this feeding pattern is in biologic opposition to human circadian rhythms (see below) and, therefore, unlikely to be pursued as a desirable weight loss intervention.
Other Religious Fasts
A study of 448 patients from hospitals in Utah found that Church of the Latterday Saints followers who reported routine fasting (29%) exhibited significantly lower weight and lower fasting glucose as well as lower prevalence of diabetes (odds ratio [OR] 0.41, 95% CI 0.17 to 0.99) and coronary stenosis (OR 0.42, 95% CI 0.21 to 0.84). 30 Seventhday Adventists emphasize a healthy diet and lifestyle as important expressions of their faith and live approximately 7.3 years longer than other white adults. This increase in life expectancy has been primarily attributed to healthful lifestyles, including not smoking, eating a plant-based diet, and regular exercise. 31 Seventh-day Adventists often consume their last of two daily meals in the afternoon, which results in a long nighttime fasting period that may be biologically important. Although it is unknown what proportion of Seventh-day Adventists adhere to a 2 meals/day pattern, this meal pattern is typically chronic, and sometimes lifelong, which would allow sufficient time to achieve stable changes in physiology. 25 However, the relationship of reduced meal frequency and prolonged nightly fasting with health among Adventists has not been studied. 32 Figure 2 illustrates how factors hypothesized to link intermittent fasting with health outcomes are related. Briefly, intermittent fasting regimens are hypothesized to influence metabolic regulation via effects on circadian biology, the gastrointestinal microbiota, and modifiable lifestyle behaviors. Negative perturbations in these systems can produce a hostile metabolic milieu, which predisposes individuals to the development of obesity, diabetes, cardiovascular disease, and cancer. See a recent review by Longo and Mattson 33 for a detailed review of the molecular mechanisms potentially linking fasting with health outcomes.
MECHANISTIC FACTORS LINKING INTERMITTENT FASTING WITH HEALTH

Circadian Biology
Intermittent fasting regimens that limit food consumption to daytime may leverage circadian biology to improve metabolic health. Organisms evolved to restrict their activity to the night or day by developing an endogenous circadian clock to ensure that physiologic processes are performed at the optimal times. 34 Time of day plays a major role in the integration of metabolism and energetics as well as physiologic indexes such as hormone secretion patterns, physical coordination, and sleep (Figure 3 ). 35 In mammals, the master biologic clock is located in the suprachiasmatic nuclei of the hypothalamus and is entrained to light and dark stimuli. Similar clock oscillators have been found in peripheral tissues such as the liver, with feeding as the dominant timing cue (ie, zeitgeber). It is hypothesized that desynchronization between the suprachiasmatic nuclei master clock and peripheral circadian clocks disrupts energy balance 36 and leads to increased risk of chronic diseases. 37 Some fasting regimens and time-restricted feeding may impose a diurnal rhythm in food intake, resulting in improved oscillations in circadian clock gene expression that reprogram molecular mechanisms of energy metabolism and body weight regulation. 22 We refer interested readers to detailed reviews on the mechanisms underlying circadian biology. [34] [35] [36] [37] [38] [39] The evidence that nutrient signals and meal timing are circadian synchronizers is based largely on animal research. 38, 39 However, in human beings there is a large and robust literature indicating that shift work disrupts circadian rhythms and is associated with increased risk of obesity, diabetes, cardiovascular disease, and cancer (particularly breast cancer). [40] [41] [42] [43] [44] Similarly, data from trials and prospective cohorts support the hypothesis that consuming the majority of the day's energy earlier in the day is associated with lower weight and improved health. [45] [46] [47] [48] [49] 
GASTROINTESTINAL (GUT) MICROBIOTA
Many functions of the gastrointestinal tract exhibit robust circadian or sleep-wake rhythms. For example, gastric emptying and blood flow are greater during the daytime than at night and metabolic responses to a glucose load are slower in the evening than in the morning. 50 Therefore, it is plausible that a chronically disturbed circadian profile may affect gastrointestinal function and impair metabolism and health. 51 Intermittent fasting may directly influence the gut microbiota, which is the complex, diverse, and vast microbial community that resides in the intestinal tract. Studies suggest that changes in composition and metabolic function of the gut microbiota in obese individuals may enable an "obese microbiota" to harvest more energy from the diet than a "lean microbiota" and thereby influence net energy absorption, expenditure, and storage. [52] [53] [54] In addition, obesityrelated changes in gut microbiota can alter gut permeability and bacterial translocation to promote systemic inflammation, 55 a hallmark of obesity and obesity-related diseases. Finally, it is notable that a recent study 56 has linked jet lag in mice and human beings to abberrant microbiota diurnal fluctuations and dysbiosis that leads to glucose intolerance and obesity.
Modifiable Lifestyle Behaviors Energy Intake. Metabolic unit studies of alternate and modified day fasting have documented decreased energy consumption. However, studies of fasting regimens in free-living adults are dependent on self-reported energy intake, which correlates poorly with objective markers of energy intake. 57 Weight change offers an indirect assessment of the effect of intermittent fasting on energy intake and, as shown in the Table, statistically significant weight reduction was observed in 85% of intermittent fasting trials. Most fasting regimens reduce the total number of hours available for eating and thereby may reduce overall energy intake and risk of obesity. In addition, research in shift and night workers has demonstrated alterations in appetite-regulating hormones (ie, leptin, ghrelin, and xenin) that may lead to increases in total energy intake. [58] [59] [60] Energy Expenditure. Animal studies indicate that the circadian clock regulates locomotion. Mice on a timerestricted, isocaloric feeding regimen have shown improved muscle coordination and increased activity and energy expenditure toward the end of the feeding period. 22 However, data in human beings are sparse or nonexistent as to whether intermittent fasting regimens affect energy expenditure among free-living adults.
Sleep. Numerous observational studies have reported that nighttime eating is associated with reduced sleep duration and poor sleep quality, 61, 62 which can lead to insulin resistance and increased risk of obesity, diabetes, cardiovascular disease, and cancer. [63] [64] [65] [66] [67] [68] Specifically, eating meals at abnormal circadian times (ie, late at night) is hypothesized to lead to circadian desynchronization 69 and subsequent disruption of normal sleep patterns. To our knowledge, no studies have directly examined associations between intermittent fasting and sleep in free-living adults.
CONCLUSIONS
It is well known that in human beings, even a single fasting interval (eg, overnight) can reduce basal concentrations of metabolic biomarkers associated with chronic disease such as insulin and glucose. For example, patients are required to fast for 8 to 12 hours before blood draws to achieve steady-state fasting levels for many metabolic substrates. Therefore, the important clinical and scientific question is whether adoption of a regular intermittent fasting regimen is a feasible and sustainable population-based strategy for promoting metabolic health. In addition, research is needed to test whether these regimens can complement or replace energy restriction and, if so, whether they support long-term weight management. Below, we briefly summarize the major conclusions that can be drawn based on the current evidence.
Studies in rodents and other nocturnal mammals support the hypothesis that intermittent fasting and restricting the availability of chow to the normal nighttime feeding cycle improves metabolic profiles and reduces the risk of obesity, obesity-related conditions such as nonalcoholic fatty liver disease, and chronic diseases such as diabetes and cancer. In healthy, normal weight, overweight, or obese adults, there is little evidence that intermittent fasting regimens are harmful physically or mentally (ie, in terms of mood). It appears that almost any intermittent fasting regimen can result in some weight loss. Among the 13 intervention trials included in this review, 11 (84.6%) reported statistically significant weight loss ranging from 1.3% in a crossover trial with a 2-week intervention 23 to 8.0% in a 1arm trial of 8 weeks' duration. 13 Based on only three studies, alternate-day fasting appears to result in weight loss as well as reductions in glucose and insulin concentrations. However, this pattern may not be practical because of intense hunger on fasting days. Modified alternate-day fasting regimens result in reduced weight, ranging from 3.2% in comparison to a control group 16 over a 12-week period to 8.0% in a one-arm trial over an 8week period. 13 There was limited and mixed evidence for reductions in insulin concentrations, improvements in lipid levels, or reductions in inflammatory factors. Research to date has not demonstrated that alternate-day fasting regimens produce superior weight loss in comparison to standard, continuous calorie restriction weight-loss plans. There are limited data from studies in human beings to support the robust rodent data regarding the positive effects of time-restricted feeding (ie, eating patterns aligned with normal circadian rhythms) on weight or metabolic health. There are considerable observational data on various forms of religious fasting, most of which suggest that these regimens result in transitory weight loss with mixed influence on other biomarkers. Data are lacking regarding the effects of intermittent fasting on other health behaviors such as diet, sleep, and physical activity. There are little or no published data linking intermittent fasting regimens with clinical outcomes such as diabetes, cardiovascular disease, cancer, or other chronic diseases such as Alzheimer disease.
A Research Agenda on Intermittent Fasting
Intermittent fasting regimens attempt to translate the positive effects of fasting regimens in rodents and other mammals into a practical eating pattern for reducing the risk of chronic disease in human beings. Below we give suggestions for a future research agenda investigating intermittent fasting and metabolic health.
Modified fasting regimens appear to promote weight loss and may improve metabolic health. However, there are insufficient data to determine the optimal fasting regimen, including the length of the fasting interval, the number of fasting days per week, degree of energy restriction needed on fasting days, and recommendations for dietary behavior on nonfasting days.
Several lines of evidence support the hypothesis that eating patterns that reduce or eliminate nighttime eating and prolong nightly fasting intervals could result in sustained improvements in human health. Although this hypothesis has not been tested in human beings, support from animal research is striking and data from time-restricted feeding studies in human beings are suggestive. Prolonged nightly fasting may be a simple, feasible, and potentially effective disease prevention strategy at the population level.
Large-scale randomized trials of intermittent fasting regimens in freeliving adults are needed and should last for at least a year to see if behavior and metabolic changes are sustainable and whether they have long-term effects on biomarkers of aging and longevity. Future studies should incorporate objective measures of energy intake, sleep, and energy expenditure; assess numerous markers of disease risk; and enroll diverse populations who disproportionately experience obesity and related health maladies.
Current recommendations for weight loss frequently include advice to eat regular meals to avoid becoming hungry. Some guidelines also advise the consumption of regular snacks throughout the day. However, it is not clear that periods of fasting (ie, hunger) necessarily lead to periods of overeating. This overview suggests that intermittent fasting regimens may be a promising approach to lose weight and improve metabolic health for people who can tolerate intervals of not eating, or eating very little, for certain hours of the day or days of the week. If shown to be efficacious, these eating regimens may offer promising nonpharmacologic approaches to improving health at the population level with multiple public health benefits. 
